I heard the 2-midnight rule is now gone based on changes to Medicare payment rates under the 2017 inpatient prospective payment system final rule. Is this true and if not what changed?
Q: Our ophthalmologists are using mitomycin after surgery for many of their patients. Do we need to report a HCPCS code for this since it gets packaged into the surgery procedure? It seems like a lot of effort for no money.
Q: One of our physicians is talking about a new biological called Inflectra that he is interested in using. Do you have any information on how this is handled under the OPPS?
